Estriol face cream: what 14 skin trials show

Estriol face cream: what 14 skin trials show

A team of dermatologists and gynecologists at the University of Iowa searched for every human trial of estrogen cream applied directly to the skin, published between 1980 and 2024. They found 14. That short list is the whole clinical record behind estriol face cream, the prescription cream now sold by telehealth brands and shown off in before and after photos across social media.

The idea behind it is sound. Skin cells carry estrogen receptors, and estrogen tells fibroblasts, the cells that build collagen, to keep working. When estrogen falls after menopause, skin gets thinner, drier and slower to repair. A cream that puts a weak estrogen straight onto the face aims to restore that signal locally, without the whole-body dose that comes with hormone therapy.

This article explains what estriol face cream is and why estrogen matters to skin, what the 14 trials found and where they fall short, what the side effect and absorption data show, and how the cream compares with tretinoin, sunscreen and collagen supplements.

Claim What the evidence shows
Estrogen cream rebuilds collagen Skin biopsies show more collagen in treated skin, mostly in areas that have seen little sun.
It visibly reduces wrinkles Trials without a placebo say yes. In a 54-woman placebo-controlled trial, the women's own ratings showed no significant improvement.
The hormone stays in the skin Not entirely. Trials recorded higher prolactin and breast tenderness, and a stronger estradiol cream raised blood estradiol 12-fold.
Vaginal estrogen cream works the same on the face Safety data from vaginal use does not transfer to daily facial use, according to a 2026 dermatology review.
Collagen supplements are the non-hormonal equivalent A 2025 meta-analysis of 23 trials found no effect in the independently funded and high-quality studies.
Tretinoin sets the standard It has consistent randomized trial evidence for sun-aged skin. No trial has compared it directly with estriol.

What estriol face cream is, and what estrogen does to skin

Estriol, often written E3, is one of three estrogens the body makes. It is the weakest of them. Estradiol, or E2, is the dominant estrogen before menopause and is far more potent. Most estriol face creams contain 0.3% estriol in a moisturizing base, made by compounding pharmacies and sold on prescription, often through telehealth companies.

Skin responds to estrogen because fibroblasts in the dermis carry estrogen receptors. When estrogen binds, fibroblasts make more type I and type III collagen and less MMP-1, the main enzyme that breaks collagen down. Estrogen also helps the outer layer hold water and keeps the epidermis thicker. Botavive's article on menopause skin aging covers that collagen decline in detail.

After the final period, the signal fades. Many women notice the change within a few years: skin that creases faster, heals slower and feels dry despite the same routine. That timing is what makes a topical hormone appealing. It targets the tissue that changed and skips the pills and patches.

Estriol is the usual choice for face creams because of its safety profile. According to a 2026 clinical review by Troxel and colleagues in JAAD Reviews, estriol has lower systemic activity and a shorter half-life than estradiol. The same review points out a catch. Most of the skin trials tested 0.01% estradiol, the strength found in several vaginal estrogen creams. A good share of the evidence quoted for estriol creams comes from a different hormone.

The biology is solid. The open question is whether a cream delivers it to your face in a form you will see in the mirror.

Infographic summarizing 14 estriol face cream trials, how topical estrogen affects skin, and an evidence comparison

Estriol face cream evidence: what 14 trials measured

The 14 studies in the 2026 review are small. Most enrolled fewer than 60 women, and several lasted between two weeks and three months. The review sorts their findings into two groups: what changed under the microscope and what changed on the face. The two groups do not line up.

The trial behind the before and after claims

The most quoted study is a 1996 trial by Schmidt and colleagues in the International Journal of Dermatology. It gave 59 women with signs of skin aging either 0.3% estriol or 0.01% estradiol cream for six months. Wrinkle depth and pore size decreased by 61 to 100% in both groups, and biopsies from 10 women showed more type III collagen. Those numbers appear on telehealth sales pages to this day.

Two details rarely travel with them. The trial had no placebo group, and every woman knew she was using a hormone cream. The women were also described as preclimacteric, meaning they had not reached menopause yet. Women buying estriol cream today are mostly past it.

What happened when a placebo was added

The 2026 review names one of the only double-blind, placebo-controlled trials with visible outcomes: Creidi and colleagues in 1994. Fifty-four women used a conjugated estrogen cream or a plain cream for 24 weeks. Clinicians rated fine wrinkles as improved in the estrogen group only. Both groups improved to a similar degree in roughness, laxity and pigmentation. When the women rated their own faces, neither group reported a significant improvement.

That gap explains most before and after photos. In two uncontrolled trials in the review, 87% and 88% of women said their face looked better. Moisturizer, better lighting, a new routine and the expectation of change all contribute. A photo cannot separate the hormone from the rest.

Why the face responds less than the hip

The review also flags a problem specific to faces. In a 2008 study by Rittié and colleagues, estradiol cream raised collagen production in hip skin, which rarely sees sun, but produced no significant response on the forearm or face. A 24-week trial by Yoon and colleagues applied estrone cream to the crow's feet area and found no improvement in wrinkles or elasticity, while MMP-1, the collagen-degrading enzyme, rose almost tenfold. The authors' explanation is that decades of UV exposure fragment the collagen network, and fibroblasts lose the tension they need to respond to estrogen.

The review's conclusion is blunt: estrogen cream shows its strongest results at the tissue level, and clinical results have not matched them.

Estriol face cream side effects and how much reaches your blood

Most women in these trials tolerated the creams well. The questions are about what happens beyond the skin, and whether decades of use are safe. Nobody has measured the second.

Skin reactions

The reported skin effects were mild: temporary redness, itching and sensitivity that cleared after stopping. In the Schmidt trial, three women developed increased pigmentation. The review found no consistent link between topical estrogen and melasma, but that finding comes from small groups followed for months, not years.

Signs the hormone travels

In the Schmidt trial, blood prolactin rose in both groups, and breast tenderness was reported by 12 of 30 women using estriol and 7 of 28 using estradiol. Breast tenderness is a classic sign of estrogen activity, and it showed up more often in the estriol group, not less. In the Rittié study, a stronger 0.2% estradiol cream raised blood estradiol about 12-fold in postmenopausal women.

The older trials measured hormones with assays that miss small rises at postmenopausal levels. The 2026 review notes that biological effects appeared at levels routine tests did not detect. Long-term data on breast or endometrial cancer risk from facial estrogen do not exist.

Using vaginal estrogen cream on your face

Some women and some prescribers use vaginal estrogen cream on the face off-label, because several of those creams contain the same 0.01% estradiol most skin trials tested. The review addresses this directly. Low-dose vaginal estrogen is considered safe for vaginal atrophy, but that safety record cannot be carried over to daily facial use. The skin area, the amount applied and the application pattern all differ, and cumulative exposure from facial use has never been studied.

If vaginal estrogen was prescribed for dryness or urinary symptoms, keep it for that job and raise the face question separately with your prescriber. Botavive's article on herbs for vaginal dryness in menopause covers the non-hormonal options for that symptom.

Pro Tip: If you start estriol cream, photograph your bare face in the same spot, at the same time of day, under the same light, before your first application and every eight weeks after. It is the only fair way to judge your own result against the before and after photos you have seen online.

How estriol compares with tretinoin, sunscreen and collagen

Estriol face cream is one option among several for skin aging after menopause, and it has the thinnest evidence base of the prescription choices. The 2026 review calls tretinoin the benchmark topical estrogen has yet to meet, because tretinoin shows consistent results in randomized trials. No study has compared the two directly.

Approach Pros Considerations Best for
Daily broad-spectrum sunscreen Prevents the UV damage that blunts collagen repair; cheap and over the counter Protects going forward, reverses little Everyone, as the base layer for any other treatment
Tretinoin (prescription retinoid) Consistent randomized trial evidence for wrinkles and sun-aged skin Dryness and peeling in the first weeks; needs a prescription Visible wrinkles and sun damage
Estriol face cream (0.3%) Raises collagen in biopsies; well tolerated on the skin Few controlled trials; some hormone absorbed; no long-term safety data; compounded Women without estrogen-related risks, under a prescriber's care
Systemic hormone therapy Treats hot flashes, sleep and bone loss alongside skin A large placebo-controlled trial found no benefit for facial wrinkles Women who need it for menopause symptoms, with skin as a side benefit
Oral collagen supplements Non-hormonal; adds protein Independent and high-quality trials show no skin effect Protein intake, not wrinkle reversal

Collagen supplements deserve a direct word, because they are often sold as the natural alternative to estrogen cream. A 2025 meta-analysis by Myung and Park in the American Journal of Medicine pooled 23 randomized trials with 1,474 participants. Across all 23, collagen appeared to improve hydration, elasticity and wrinkles. When the authors separated the trials by funding, the studies without pharmaceutical funding showed no effect. The high-quality studies showed no effect either. Botavive's collagen buyer's guide explains what to look for if you take one anyway.

A reasonable order of operations starts with sunscreen every day, adds a retinoid if your skin tolerates it, and treats estriol cream as an optional third step discussed with a dermatologist or menopause specialist. Hormone therapy is a decision about hot flashes, sleep and bones first. Only a small share of women use it, as covered in Botavive's article on hormone therapy use dropping to 1.7%.

Know when to seek professional evaluation:

  • You have had breast cancer or another estrogen-sensitive cancer and are considering any estrogen product
  • You have unexplained vaginal bleeding, or any bleeding after 12 months without a period
  • You have a history of blood clots, stroke or liver disease
  • You already use hormone therapy and want to add estrogen to your face
  • Breast tenderness, spotting or new skin darkening appears after starting a cream
  • A telehealth service offers estriol cream without asking about your medical history

Woman in her fifties in a white robe resting her chin on her hand beside a jar of face cream in a bathroom

Where Botavive Glow fits in a skin plan after 40

Every approach in the table depends on skin being able to build collagen, and fibroblasts need raw materials to do it. Vitamin C is a required cofactor for the enzymes that stabilize new collagen fibers. A cream on the surface does not correct a diet that runs short on it, and neither does a prescription.

Botavive Glow covers that nutrient side. A two-capsule serving provides 120 mg of vitamin C along with vitamins A and E, zinc, 5,000 mcg of biotin, and horsetail and bamboo extracts. Glow contains no estrogen or other hormones, and it contains no collagen. It supplies nutrients that skin, hair and nails use every day. Glow contains soy.

Glow does not smooth wrinkles or replace sunscreen, a retinoid or medical advice about estrogen. It is one daily habit inside a broader plan, useful whether or not you ever fill a prescription for estriol face cream.

Frequently asked questions

Does estriol face cream work?

It changes skin under the microscope. Biopsy studies show more collagen and a thicker epidermis in treated skin. Visible results are less certain: in the placebo-controlled trial highlighted by a 2026 review, women rating their own faces saw no significant improvement, and sun-damaged facial skin responded less than protected skin.

What do estriol face cream before and after photos show?

They show a change, not its cause. In uncontrolled trials, 87% and 88% of women reported looking better, but lighting, angle, moisturizer and expectation all shift a photo. Only trials with a placebo group separate the hormone's effect from the rest, and those trials show smaller changes.

Is estriol face cream safe?

Short-term trials reported mostly mild skin reactions such as redness and itching. Some hormone reaches the bloodstream: prolactin rose and 12 of 30 estriol users reported breast tenderness in one trial. No long-term cancer data exist, so women with estrogen-sensitive cancer, unexplained bleeding or a clotting history need a doctor's input first.

Can you use vaginal estrogen cream on your face?

Some prescribers allow it off-label, because several vaginal creams contain the 0.01% estradiol used in skin trials. A 2026 dermatology review warns that vaginal safety data do not transfer to daily facial use, since the area, amount and pattern of application differ. Ask the prescriber before repurposing any hormone cream.

Is estriol face cream better than tretinoin?

There is no direct comparison. Tretinoin has consistent evidence from randomized trials for wrinkles and sun damage, and reviewers treat it as the benchmark estrogen cream has not yet met. Some women use both, and that combination is best set up with a dermatologist.

Sources

  1. Troxel J, Correa Ferrer L, Iwamoto A, Van Voorhis BJ, Powers JG, 2026. Topical estrogen therapy for aging skin: current evidence and clinical considerations. JAAD Reviews, 7, 73 to 80. jaadreviews.org/article/S2950-1989(25)00103-5/fulltext
  2. Schmidt JB, Binder M, Demschik G, Bieglmayer C, Reiner A, 1996. Treatment of skin aging with topical estrogens. International Journal of Dermatology, 35(9), 669 to 674. pubmed.ncbi.nlm.nih.gov/8876303
  3. Myung SK, Park Y, 2025. Effects of collagen supplements on skin aging: a systematic review and meta-analysis of randomized controlled trials. American Journal of Medicine, 138(9), 1264 to 1277. pubmed.ncbi.nlm.nih.gov/40324552

Related articles

Previous post Next post
Back to blog

Leave a comment

Please note, comments need to be approved before they are published.